511509 — Vivo Bio Tech Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSuper Stock

Annual income statement for Vivo Bio Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	558	554	518	514	522
Cost of Revenue
Gross Profit	441	468	446	400	455
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	514	481	397	430	400
Operating Profit	44.5	73	121	83.7	122
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	18.2	42.5	86.2	44.7	46.2
Provision for Income Taxes
Net Income After Taxes	22.5	44.4	56.8	22	26.5
Net Income Before Extraordinary Items
Net Income	22.5	44.4	56.8	22	26.5
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	22.5	44.4	56.8	22	26.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.08	3.45	4.23	1.55	1.79